The ACA has contributed to hospitals seeing higher volumes of insured patients, and those volumes would drop if the ACA is repealed or materially replaced, according to Fitch.
Fitch noted a repeal of the ACA may also slow the transition to value-based payment models and cause fewer people to keep prescription coverage, which would be modestly negative for the pharmaceutical industry.
More articles on healthcare finance:
Kindred to close Texas hospital, leaving 92 without jobs
Retired cardiologist says hospitals’ quest for profits fuels higher healthcare costs
UPMC operating margin shrinks in Q1
